Diaminopyridine compounds and methods of use

作者: Dilip R. Wagle , Anthony Cerami , Peter C. Ulrich

DOI:

关键词:

摘要: The present invention relates to compositions and method for inhibiting nonenzymatic cross-linking (protein aging) which contain diaminopyridines derivates thereof. Accordingly, a composition is disclosed comprises an agent capable of the formation advanced glycosylation endproducts target proteins by reacting with carbonyl moiety early product such formed their initial glycosylation. contacting protein composition. Both industrial therapeutic applications are envisioned, as food spoilage animal aging can be treated.

参考文章(3)
Gary E. Gibson, Christine J. Peterson, Diaminopyridines to improve cognition ,(1982)
Christopher T. Bever, James Leslie, David L. Camenga, Hillel S. Panitch, Kenneth P. Johnson, Preliminary trial of 3,4‐diaminopyridine in patients with multiple sclerosis Annals of Neurology. ,vol. 27, pp. 421- 427 ,(1990) , 10.1002/ANA.410270411
Kathleen M. McEvoy, Anthony J. Windebank, Jasper R. Daube, Phillip A. Low, 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. The New England Journal of Medicine. ,vol. 321, pp. 1567- 1571 ,(1989) , 10.1056/NEJM198912073212303